Evolution of IL-23 Blockade in Inflammatory Bowel Disease

被引：2
|
作者：
Danese, Silvio [1 ,2 ]
Peyrin-Biroulet, Laurent [3 ,4 ]
机构：
[1] IRCCS San Raffaele, Gastroenterol & Endoscopy, Via Olgettina 60, I-20132 Milan, Italy
[2] Univ Vita Salute, Via Olgettina 60, I-20132 Milan, Italy
[3] Lorraine Univ, Dept Hepato Gastroenterol, Vandoeuvre Les Nancy, France
[4] Lorraine Univ, INSERM, U1256, Univ Hosp Nancy, Vandoeuvre Les Nancy, France
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷 / SUPPL 2期
关键词：
IBD;
D O I：
10.1093/ecco-jcc/jjab188
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The IL-23/IL-17 pathway in inflammatory bowel disease
    Geremia, Alessandra
    Jewell, Derek P.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (02) : 223 - 237
  • [2] The Role of IL-23 in the Pathogenesis and Therapy of Inflammatory Bowel Disease
    Korta, Aleksandra
    Kula, Julia
    Gomulka, Krzysztof
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
  • [3] Are all the IL-23 blockers the same in inflammatory bowel disease?
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2024, 21 (03) : 138 - 139
  • [4] Are all the IL-23 blockers the same in inflammatory bowel disease?
    Silvio Danese
    Laurent Peyrin-Biroulet
    Nature Reviews Gastroenterology & Hepatology, 2024, 21 : 138 - 139
  • [5] IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
    Verstockt, Bram
    Salas, Azucena
    Sands, Bruce E.
    Abraham, Clara
    Leibovitzh, Haim
    Neurath, Markus
    Vande Casteele, Niels
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (07) : 433 - 446
  • [6] Differential roles for IL-23 and IL-17 in inflammatory bowel disease
    Towne, J. E.
    Maxwell, J. R.
    Zhang, Y.
    Brown, W. A.
    Rottman, J. B.
    Budelsky, A. L.
    CYTOKINE, 2012, 59 (03) : 515 - 515
  • [7] IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
    Bram Verstockt
    Azucena Salas
    Bruce E. Sands
    Clara Abraham
    Haim Leibovitzh
    Markus F. Neurath
    Niels Vande Casteele
    Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 433 - 446
  • [8] Biomarkers of Therapeutic Response in the IL-23 Pathway in Inflammatory Bowel Disease
    Cayatte, Corinne
    Joyce-Shaikh, Barbara
    Vega, Felix
    Boniface, Katia
    Grein, Jeffrey
    Murphy, Erin
    Blumenschein, Wendy M.
    Chen, Smiley
    Malinao, Maria-Christina
    Basham, Beth
    Pierce, Robert H.
    Bowman, Edward P.
    McKenzie, Brent S.
    Elson, Charles O.
    Faubion, William A.
    Malefyt, Rene de Waal
    Kastelein, Robert A.
    Cua, Daniel
    McClanahan, Terrill K.
    Beaumont, Maribel
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2012, 3
  • [9] IL-23 and Autoimmunity: New Insights into the Pathogenesis of Inflammatory Bowel Disease
    Abraham, Clara
    Cho, Judy H.
    ANNUAL REVIEW OF MEDICINE, 2009, 60 : 97 - 110
  • [10] INTERLEUKIN-23 (IL-23) AS A MARKER OF DISEASE ACTIVITY IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
    Goldfarb, Alexa
    Greifer, Melanie
    Levine, Jeremiah
    GASTROENTEROLOGY, 2023, 164 (06) : S497 - S497
12345